IGC Pharma
IGC
#10741
Rank
A$30.52 M
Marketcap
A$0.30
Share price
2.20%
Change (1 day)
-49.48%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -A$9.75 Million

According to IGC Pharma's latest financial reports the company's current earnings are A$1.18 Million. In 2025 the company made an earning of -A$7.72 Million, an increase over its 2024 earnings that were of -A$12.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.75 Million26.21%
2025 -A$7.72 Million-39.35%
2024 -A$12.73 Million-37.72%
2023 -A$20.44 Million1.19%
2022 -A$20.2 Million21.96%
2021 -A$16.56 Million27.13%
2020 -A$13.03 Million57.16%
2019 -A$8.29 Million85.47%
2018 -A$4.47 Million52.76%
2017 -A$2.93 Million-16.23%
2016 -A$3.5 Million-28.75%
2015 -A$4.91 Million-19.59%
2014 -A$6.1 Million6.79%
2013 -A$5.71 Million-9.47%
2012 -A$6.31 Million-74.03%
2011 -A$24.28 Million119.78%
2010 -A$11.05 Million62.02%
2009 -A$6.82 Million74.39%
2008 -A$3.91 Million-313.12%
2007 A$1.83 M-35.94%
2006 A$2.86 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
A$1.12 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
A$1.05 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-A$96.05 Million 915.47%๐Ÿ‡บ๐Ÿ‡ธ USA